Literature DB >> 12857578

CD56 in T-cell acute lymphoblastic leukaemia: a malignant transformation of an early myeloid-lymphoid progenitor?

Isabel Montero1, Eduardo Rios, Ricardo Parody, Jose M Perez-Hurtado, Antonio Martin-Noya, Juan Manuel Rodriguez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12857578

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  8 in total

1.  CD56 expression in T-cell acute lymphoblastic leukemia is associated with non-thymic phenotype and resistance to induction therapy but no inferior survival after risk-adapted therapy.

Authors:  Lars Fischer; Nicola Gökbuget; Stefan Schwartz; Thomas Burmeister; Harald Rieder; Monika Brüggemann; Dieter Hoelzer; Eckhard Thiel
Journal:  Haematologica       Date:  2008-12-23       Impact factor: 9.941

2.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

3.  Naso-Sinusal T ALL With Aberrant Expression of CD56 Mimicking NK/T Non Hodgkin Lymphoma.

Authors:  Marielle Igala; Sofia Marouan; Jennie Okouango Ova; Mouna Lamchahab; Asmae Quessar; Said Benchekroun
Journal:  Indian J Hematol Blood Transfus       Date:  2014-08-22       Impact factor: 0.900

4.  T-cell acute lymphoblastic leukemia with co-expression of CD56, CD34, CD117 and CD33: A case with poor prognosis.

Authors:  Rafet Eren; Ceyda Aslan; Osman Yokuş; Mehmet Hilmi Doğu; Elif Suyani
Journal:  Mol Clin Oncol       Date:  2016-06-13

5.  Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group.

Authors:  Olga K Weinberg; Karen M Chisholm; Chi Young Ok; Yuri Fedoriw; Bartosz Grzywacz; Jason H Kurzer; Emily F Mason; Karen A Moser; Siddharth Bhattacharya; Mina Xu; Daniel Babu; Kathryn Foucar; Wayne Tam; Adam Bagg; Attilio Orazi; Tracy I George; Wei Wang; Sa A Wang; Daniel A Arber; Robert P Hasserjian
Journal:  Mod Pathol       Date:  2021-02-01       Impact factor: 7.842

Review 6.  A narrative review of central nervous system involvement in acute leukemias.

Authors:  Dalma Deak; Nicolae Gorcea-Andronic; Valentina Sas; Patric Teodorescu; Catalin Constantinescu; Sabina Iluta; Sergiu Pasca; Ionut Hotea; Cristina Turcas; Vlad Moisoiu; Alina-Andreea Zimta; Simona Galdean; Jakob Steinheber; Ioana Rus; Sebastian Rauch; Cedric Richlitzki; Raluca Munteanu; Ancuta Jurj; Bobe Petrushev; Cristina Selicean; Mirela Marian; Olga Soritau; Alexandra Andries; Andrei Roman; Delia Dima; Alina Tanase; Olafur Sigurjonsson; Ciprian Tomuleasa
Journal:  Ann Transl Med       Date:  2021-01

7.  Relevance of flow cytometric categorization and end-of-induction measurable residual disease assessment in pediatric and adult T-lymphoblastic leukemia patients.

Authors:  Karthik Bommannan; Jhansi Rani Arumugam; Venkatraman Radhakrishnan; Jayachandran Perumal Kalaiyarasi; Parathan Karunakaran; Nikita Mehra; Tenali Gnana Sagar; Shirley Sundersingh
Journal:  Blood Res       Date:  2022-07-27

8.  Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia.

Authors:  Hamilton L Gimenes-Teixeira; Antonio R Lucena-Araujo; Guilherme A Dos Santos; Dalila L Zanette; Priscila S Scheucher; Luciana C Oliveira; Leandro F Dalmazzo; Wilson A Silva-Júnior; Roberto P Falcão; Eduardo M Rego
Journal:  Exp Hematol Oncol       Date:  2013-04-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.